| 5.9 0.03 (0.51%) | 07-15 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term | |
|||
| Targets | 6-month : | 7.79 | 1-year : | 9.09 |
| Resists | First : | 6.67 | Second : | 7.79 |
| Pivot price | 3.4  |
|||
| Supports | First : | 4.09 |
Second : | 2.5 |
| MAs | MA(5) : | 4.33 |
MA(20) : | 3.26 |
| MA(100) : | 2.77 |
MA(250) : | 2.63 |
|
| MACD | MACD : | 0.5 |
Signal : | 0.2 |
| %K %D | K(14,3) : | 80  |
D(3) : | 81.1 |
| RSI | RSI(14): 94.2 |
|||
| 52-week | High : | 6.67 | Low : | 1.91 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ MGRM ] has closed above the upper band by 13.1%. If price is in a uptrend band; this upward trend in price might continue. However a short term pullback inside the band is likely.Bollinger Bands are 401.5% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 1 days. This is a sign that the current trend might continue.
| If tomorrow: | Open lower | Open higher |
| High: | 6.68 - 6.71 | 6.71 - 6.74 |
| Low: | 5.11 - 5.14 | 5.14 - 5.16 |
| Close: | 5.82 - 5.87 | 5.87 - 5.92 |
Monogram Orthopaedics, Inc. focuses on developing a product solution architecture to enable mass personalized optimization of orthopedic implants. The company intends to produce and market robotic surgical equipment and related software, orthopedic implants, tissue ablation tools, navigation consumables, and other miscellaneous instrumentation for use in reconstructive joint replacement procedures. Its robot prototype executes optimized paths for high-precision insertion of optimized implants in synthetic bone specimens. The company was formerly known as Monogram Arthroplasty Inc. and changed its name to Monogram Orthopaedics, Inc. in March 2017. The company was incorporated in 2016 and is headquartered in Austin, Texas.
Mon, 14 Jul 2025
Monogram Orthopaedics Ends License Agreement with Mount Sinai - TipRanks
Mon, 14 Jul 2025
Monogram Orthopaedics Enters Merger Agreement with Zimmer Biomet - TipRanks
Mon, 14 Jul 2025
Zimmer Biomet's $177M Monogram Deal Brings First-Ever Autonomous Surgical Robot to Orthopedics - Stock Titan
Wed, 09 Jul 2025
Monogram Orthopaedics Initiates Mandatory Stock Conversion - The Globe and Mail
Tue, 08 Jul 2025
Monogram Orthopaedics, Inc. (NASDAQ:MGRM) Q1 2025 Earnings Call Transcript - MSN
Sun, 04 May 2025
MGRM - Monogram Orthopaedics Inc Latest Stock News & Market Updates - Stock Titan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Devices
|
|
| Shares Out | 36 (M) |
| Shares Float | 26 (M) |
| Held by Insiders | 33.5 (%) |
| Held by Institutions | 5.1 (%) |
| Shares Short | 467 (K) |
| Shares Short P.Month | 401 (K) |
| EPS | -0.5 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 0.33 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -67.4 % |
| Return on Equity (ttm) | -146.1 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -0.41 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -13 (M) |
| Levered Free Cash Flow | -8 (M) |
| PE Ratio | -11.81 |
| PEG Ratio | 0 |
| Price to Book value | 17.87 |
| Price to Sales | 0 |
| Price to Cash Flow | -16.68 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|